World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
96
Citations
36716
World Ranking
9597
National Ranking
4942

Edward P. Gelmann publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Edward P. Gelmann sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 242 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Edward P. Gelmann D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Edward P. Gelmann sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 96 D-Index — 53rd percentile

53% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Edward P. Gelmann is affiliated with the University of Arizona in the United States. Their research primarily focuses on medicine, with significant contributions to pulmonary and respiratory medicine, oncology, epidemiology, genetics, and molecular biology. The main topics of their work include prostate cancer treatment and research, renal cell carcinoma treatment, cancer immunotherapy and biomarkers, neuroendocrine tumor research advances, neuroblastoma research and treatments, lung cancer research studies, and estrogen-related hormone effects.

The scientist has contributed to several recent publications, including:

  • Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors (2024) - The Oncologist
  • Androgen-targeting therapeutics mitigate the adverse effect of GnRH agonist on the risk of neurodegenerative disease in men treated for prostate cancer (2022) - Cancer Medicine
  • CRISPR/Cas9-Mediated Point Mutation in Nkx3.1 Prolongs Protein Half-Life and Reverses Effects Nkx3.1 Allelic Loss (2020) - Cancer Research
  • A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with advanced or metastatic renal cell carcinoma (2025) - Journal of Clinical Oncology
  • The expanding role of hormones in cancer (2021) - Endocrine Oncology

Edward P. Gelmann frequently publishes in the following venues:

  • Journal of Clinical Oncology (3 publications)
  • Cancer Research (2 publications)
  • The Oncologist (1 publication)
  • Cancer Medicine (1 publication)
  • Endocrine Oncology (1 publication)

The scientist collaborates regularly with several coauthors, including:

  • Bilal A. Siddiqui
  • Benedito A. Carneiro
  • Mark N. Stein
  • Jingsong Zhang
  • David R. Wise

Overall, Edward P. Gelmann's work intersects multiple subfields of medicine, with a strong emphasis on cancer research and hormonal effects related to oncological conditions.

Best Publications

  • Mortality Results from a Randomized Prostate-Cancer Screening Trial

    Gerald L. Andriole;E. David Crawford;Robert L. Grubb;Saundra S. Buys

  • Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

    Robert C. Gallo;Prem S. Sarin;E. P. Gelmann;Marjorie Robert-Guroff

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Meredith Yeager;Nick Orr;Richard B Hayes;Kevin B Jacobs

  • Molecular Biology of the Androgen Receptor

    Edward P. Gelmann

  • Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations

    A S Fauci;A M Macher;D L Longo;H C Lane

  • Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

    Philip C Prorok;Gerald L Andriole;Robert S. Bresalier;Saundra S Buys

  • ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX

    Robert Yarchoan;Kent J. Weinhold;H. Kim Lyerly;Edward Gelmann

  • Cryptococcosis in the acquired immunodeficiency syndrome.

    Joseph A. Kovacs;Andrea A. Kovacs;Michael Polis;W. Craig Wright

  • Expression of cellular homologues of retroviral onc genes in human hematopoietic cells

    E H Westin;F Wong-Staal;E P Gelmann;R Dalla-Favera

  • The Ubiquitin-Proteasome Pathway and Its Role in Cancer

    Aparna Mani;Edward P. Gelmann

  • Physical properties of membrane lipids: biological relevance and regulation.

    J E Cronan;E P Gelmann

  • Malignant Pheochromocytoma: Effective Treatment with a Combination of Cyclophosphamide, Vincristine, and Dacarbazine

    Steven D. Averbuch;Caryn S. Steakley;Robert C. Young;Edward P. Gelmann

  • Loss of NKX3.1 Expression in Human Prostate Cancers Correlates with Tumor Progression1,2

    Cai Bowen;Lukas Bubendorf;H. James Voeller;Rebecca Slack

  • A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer.

    W W He;P J Sciavolino;J Wing;M Augustus

  • β-Catenin Mutations in Human Prostate Cancer

    H J Voeller;C I Truica;E P Gelmann

  • Autocrine and paracrine growth regulation of human breast cancer

    Marc E. Lippman;Robert B. Dickson;Susan Bates;Cornelius Knabbe

  • β-Catenin Affects Androgen Receptor Transcriptional Activity and Ligand Specificity

    Cristina I. Truica;Stephen Byers;Edward P. Gelmann

  • Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

    R Dalla-Favera;E P Gelmann;S Martinotti;G Franchini

  • The Acquired Immunodeficiency Syndrome: An Update

    Fauci As;Masur H;Gelmann Ep;Markham Pd

  • Genome-wide association study of prostate cancer identifies a second risk locus at 8q24

    Adam S. Kibel

Frequent Co-Authors

Henry Masur
Henry Masur National Institutes of Health
Robert C. Gallo
Robert C. Gallo University of South Florida
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Marc E. Lippman
Marc E. Lippman National Institutes of Health
Flossie Wong-Staal
Flossie Wong-Staal University of California, San Diego
Paul F. Pinsky
Paul F. Pinsky National Institutes of Health
Gerald L. Andriole
Gerald L. Andriole Washington University in St. Louis
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
David Chia
David Chia University of California, Los Angeles
Barnett S. Kramer
Barnett S. Kramer National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine can open doors to diverse allied health fields. Many students are searching for flexible options and alternative pathways to build their future in healthcare without following a traditional MD route.

For instance, aspiring nurses can enroll in absn programs that don't require teas, avoiding standardized test requirements and accelerating their journey to becoming an RN. Another in-demand choice is pursuing online health administration programs, perfect for those interested in management and leadership roles within medical organizations.

Registered nurses seeking career advancement can bridge their current qualification with specialized practice by enrolling in an rn to np bridge program. These programs are designed for working professionals and are often delivered in a hybrid or online format.

Additionally, nutrition-focused students can consider an online dietitian degree, enabling flexible study while preparing for roles in health promotion, clinical nutrition, or wellness coaching.

Online and accelerated healthcare degrees are excellent alternatives for those looking to build fulfilling careers in medicine-related fields without attending traditional, lengthy programs.

Best Scientists Citing Edward P. Gelmann

Trending Scientists

Recently Published Articles